Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Sevoflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Breast Neoplasms 8 Colonic Neoplasms 7 Lung Neoplasms 5 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Carcinoma, Hepatocellular 3 Respiratory Aspiration 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Postoperative Complications 2 Pituitary Neoplasms 2 Ovarian Neoplasms 2 Neoplastic Cells, Circulating 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Quality of Recovery 1 Postoperative Cognitive Complications 1 Pain, Postoperative 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Myofibroma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Liver Functions Tests 1 Kidney Neoplasms 1 Intraoral Tumor 1

Interventions

Bupivacaine 9 Ketamine 8 Analgesics, Opioid 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Oxycodone 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡